Stanford University · Biomedical EngineeringCancer Metabolism and Imaging Lab
Daniel M Spielman · Stanford, California
Research Focus
Dr. Daniel M Spielman's lab at Stanford University is focused on innovative cancer therapies and imaging techniques. Their aim is to improve the treatment and diagnosis of resistant cancers like glioblastoma by utilizing novel lipid-based drugs that target tumor energy metabolism. By developing advanced MRI techniques, the lab is working to better understand metabolic changes in tumors and enhance treatment response monitoring.
glioblastomacancer therapyMRI imagingdeuterium metabolic imaginglipid nanoemulsion
Research Aims
4AIM 01Develop novel MRI techniques to monitor cancer metabolism.
AIM 02Investigate the effects of a lipid nanoemulsion drug on glioblastoma cells.
AIM 03Enhance imaging methods to assess treatment response in brain tumors.
AIM 04Explore the role of metabolic reprogramming in cancer progression.
Skills the Lab Values
Magnetic Resonance Imaging (MRI)Magnetic Resonance Spectroscopy (MRS)Deuterium metabolic imaging (DMI)Cell culture techniquesAnimal models of cancer
Output against the department
Publications228top 45% of dept.268th of 595
this lab
most publishedleast published
Citations7.8ktop 45% of dept.266th of 595
this lab
most citedleast cited
Career totals from OpenAlex, compared against labs that share a department. A department spans everything from one paper to tens of thousands, so bar heights are on a log scale — otherwise the largest lab would flatten every other bar to a line.